Literature DB >> 9231813

Ambulatory and home blood pressure normality in the elderly: data from the PAMELA population.

R Sega1, G Cesana, C Milesi, G Grassi, A Zanchetti, G Mancia.   

Abstract

To determine ambulatory blood pressure (BP) means and distributions in an elderly population, we studied a random sample of 800 subjects stratified by sex and representative of residents aged 65 to 74 years of the city of Monza. Participation was 50%. Measurements consisted of clinic BP (average of three measurements with mercury sphygmomanometry), home BP (average of morning and evening measurements with a semiautomatic device), and ambulatory BP (SpaceLabs 90207). Clinic BP was obtained before and after home and ambulatory BP measurements. In normotensive and untreated hypertensive subjects (n=248), clinic, home, and ambulatory BPs were significantly related (P<.001). The means of the clinic BPs obtained on consecutive days were very similar and markedly higher than 24-hour average BP (+25 mm Hg systolic and + 10 mm Hg diastolic, P<.001). Nighttime BP was markedly less than daytime BP (-14 and -13 mm Hg, P<.001), whereas home BP values occurred approximately midway between clinic and 24-hour average BP values. Only minor differences existed between data in men and women, and the differences in clinic, home, and ambulatory BP values occurred in both normotensive and untreated hypertensive subjects. All BPs were similar in the untreated and treated hypertensive groups. Thus, as previously reported in subjects younger than 65 years, in the elderly fraction of the population, 24-hour average BP is much lower than clinic BP. The upper limit of normality for 24-hour average BP (calculated as the value corresponding to 140/90 mm Hg clinic BP) is about 120 mm Hg systolic and 76 mm Hg diastolic. At variance with data from younger subjects, home BP in the elderly is higher than 24-hour average BP. However, similar to data from younger subjects, clinic, home, and ambulatory BPs are higher in treated hypertensive than normotensive elderly subjects, indicating that in hypertensive elderly subjects, antihypertensive treatment does not commonly achieve full BP control both inside and outside the clinic environment.

Entities:  

Mesh:

Year:  1997        PMID: 9231813     DOI: 10.1161/01.hyp.30.1.1

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  20 in total

Review 1.  Big Data and Blood Pressure Control: Insights from the PAMELA and BP-CARE Study Cohorts.

Authors:  M Bombelli; Rita Facchetti; Giuseppe Mancia; Guido Grassi
Journal:  Curr Hypertens Rep       Date:  2018-07-26       Impact factor: 5.369

Review 2.  The Pamela study: main findings and perspectives.

Authors:  Michele Bombelli; Elena Toso; Maria Peronio; Danilo Fodri; Marco Volpe; Gianmaria Brambilla; Rita Facchetti; Roberto Sega; Guido Grassi; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

Review 3.  White Coat Hypertension and Cardiovascular Diseases: Innocent or Guilty.

Authors:  Mehran Abolbashari
Journal:  Curr Cardiol Rep       Date:  2018-03-08       Impact factor: 2.931

Review 4.  Ambulatory Blood Pressure Monitoring: A Complementary Strategy for Hypertension Diagnosis and Management in Low-Income and Middle-Income Countries.

Authors:  Marwah Abdalla
Journal:  Cardiol Clin       Date:  2017-02       Impact factor: 2.213

Review 5.  Diagnosis and management of patients with white-coat and masked hypertension.

Authors:  Giuseppe Mancia; Michele Bombelli; Gino Seravalle; Guido Grassi
Journal:  Nat Rev Cardiol       Date:  2011-08-09       Impact factor: 32.419

6.  Age and the difference between awake ambulatory blood pressure and office blood pressure: a meta-analysis.

Authors:  Joji Ishikawa; Yukiko Ishikawa; Donald Edmondson; Thomas G Pickering; Joseph E Schwartz
Journal:  Blood Press Monit       Date:  2011-08       Impact factor: 1.444

Review 7.  Modern approaches to blood pressure measurement.

Authors:  J A Staessen; E T O'Brien; L Thijs; R H Fagard
Journal:  Occup Environ Med       Date:  2000-08       Impact factor: 4.402

8.  Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients.

Authors:  Raffaella Dell'Oro; Alessandro Maloberti; Francesco Nicoli; Paolo Villa; Pierluigi Gamba; Michele Bombelli; Giuseppe Mancia; Guido Grassi
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-06-12

9.  Predictors of the community pharmacy white-coat effect in treated hypertensive patients. The MEPAFAR study.

Authors:  Daniel Sabater-Hernández; Pablo Sánchez-Villegas; José P García-Corpas; Pedro Amariles; José Sendra-Lillo; María J Faus
Journal:  Int J Clin Pharm       Date:  2011-04-27

10.  Franz Volhard lecture: should doctors still measure blood pressure? The missing patients with masked hypertension.

Authors:  Thomas G Pickering; William Gerin; Joseph E Schwartz; Tanya M Spruill; Karina W Davidson
Journal:  J Hypertens       Date:  2008-12       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.